The most frequent monocyte alterations in MDS are (1) increased or decreased monocyte number, (2) abnormal intensity of CD13, CD33, CD14, CD36, CD45, or CD64 expression, and (3) altered CD11b/HLA-DR or CD36/CD14 ratios (33). This evidence concerns the gene CD14 and myelodysplastic syndrome.